网红黑料

Skip to main content
(352) 273-8740

Ali Ataya, MD : Research

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Ali Ataya
(352) 273-8740 MyUF网红黑料

Research at a glance

Top areas of exploration

  • Dyspnea , 10 publications
  • Pulmonary Alveolar Proteinosis , 4 publications
  • Lymphangioleiomyomatosis , 4 publications
  • Fever , 4 publications

Research activity

122 publications

396 citations

Why is this important?

Active clinical trials

United therapeutics 301

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World 网红黑料 Organization (WHO)鈥�

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
Sapphire

This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with sarcoidosis-associated interstitial lung disease and pulmonary hypertension.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - 99 Years
Sexes
All

My publications

122 publications

2024

Diffuse hyperdense micronodular airspace opacities in pulmonary alveolar microlithiasis

Thorax

2024

Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus

Respiratory Medicine

2024

Progressive Dyspnea on Exertion in an 82-Year-Old.

JAMA

鈥�

2024

Progressive Exertional Dyspnea in a Patient with Epistaxis, Telangiectasias, and Arteriovenous Malformations

Annals of the American Thoracic Society

2024

Pulmonary hypertension during high鈥恉ose GM鈥怌SF therapy of autoimmune pulmonary alveolar proteinosis

Pulmonary Circulation